Novartis Ag (NVSEF) Non Operating Income (2009 - 2017)

Novartis Ag has disclosed Non Operating Income across 7 years of filings, most recently posting $183.0 million for Q3 2017.

• Non Operating Income for Q3 2017 came in at $183.0 million, down 13.68% year-over-year; the trailing twelve-month figure through Sep 2017 was $1.1 billion (down 7.73% YoY), and the FY2016 annual result was $409.0 million, changed N/A from the prior year.
• Non Operating Income came in at $183.0 million for Q3 2017 at Novartis Ag, up from $180.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $556.0 million in Q4 2015 to a low of $122.0 in Q1 2015.
• The 5-year median for Non Operating Income is $246.0 (2015), against an average of $128.8 million.
• Across the five-year window, Non Operating Income slumped 37.5% in 2014 and soared 317714185.71% in 2015, its largest moves.
• Novartis Ag's Non Operating Income stood at $205.0 in 2013, then slipped by 14.63% to $175.0 in 2014, then jumped by 317714185.71% to $556.0 million in 2015, then dropped by 4.14% to $533.0 million in 2016, then tumbled by 65.67% to $183.0 million in 2017.
• The last three Non Operating Income figures came in at $183.0 million (Q3 2017), $180.0 million (Q2 2017), and $190.0 million (Q1 2017), per Business Quant data.